Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT06462768
Eligibility Criteria:
Inclusion Criteria:
\*For patients of group 1:
* Patients with systemic sclerosis (ACR-EULAR Criteria)
* Patients taking care of in internal medicine or in dermatology department's of the university hospital of Reims
* Patients consenting to participate to the study
* Patients enrolled in the national healthcare insurance program
For patients of group 2:
* Patients with other connective tissue disease (ACR specific-disease criteria)
* Patients taking care of in internal medicine or in dermatology department's of the university hospital of Reims
* Patients consenting to participate to the study
* Patients enrolled in the national healthcare insurance program
For patients of group 3 (healthy volunteers)
* Patients eligible for blood donation (blood donation regulation criteria of January 11th 2022 decree)
* Patients without medical history of autoimmune systemic or chronic inflammatory systemic disease,
* Patients without current or past neoplasy disease,
* Patients without chronic metabolic pathology
* Patients without treatment by anti inflammatory or corticotherapy for the last 15 days,
* Patients without infectious pathology or inflammatory acute for the last 15 days
* Patients consenting to participate to the study
Exclusion Criteria for patients of all groups:
* Patients/Healthy volunteers under 18 years old
* Patients/Healthy volunteers protected by the law
* Patients/Healthy volunteers not consenting to participate to the study after information
* Patients with inflammatory pathology or infectious acute intercurrent pathology in the last 15 days before inclusion
* Pregnant or breastfeeding women
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06462768
Study Brief:
Protocol Section:
NCT06462768